Neurodegenerative disorders and hyperaldosteronism.
D000293:Adolescent; D000450:Aldosterone / Q000378:metabolism; D000804:Angiotensin II / Q000097:blood; D001724:Birth Weight; D001794:Blood Pressure; D001835:Body Weight; D002037:Bundle-Branch Block / Q000150:complications; D002493:Central Nervous System Diseases / Q000150:complications*; D002556:Cerebrospinal Fluid Proteins / Q000032:analysis; D002648:Child; D004562:Electrocardiography; D004569:Electroencephalography; D004576:Electromyography; D005128:Eye Diseases / Q000150:complications*; D005260:Female; D006801:Humans; D006929:Hyperaldosteronism / Q000150:complications* / Q000188:drug therapy; D007360:Intelligence; D004684:Leukoencephalitis, Acute Hemorrhagic / Q000150:complications; D008274:Magnesium / Q000097:blood; D008297:Male; D009410:Nerve Degeneration; D011188:Potassium / Q000097:blood / Q000652:urine; D012164:Retinal Diseases / Q000150:complications; D012168:Retinal Pigments; D012964:Sodium / Q000652:urine; D013148:Spironolactone / Q000008:administration & dosage
D002556:Cerebrospinal Fluid Proteins; D012168:Retinal Pigments; D000804:Angiotensin II; D013148:Spironolactone; D000450:Aldosterone; D012964:Sodium; D008274:Magnesium; D011188:Potassium